Search

Search Constraints

You searched for: Author/Creator Carleton, Bruce C.

Search Results

1. Analyses of Adverse Drug Reactions–Nationwide Active Surveillance Network: Canadian Pharmacogenomics Network for Drug Safety Database. (19th November 2018)

4. Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update. Issue 4 (2nd February 2018)

5. Clinical Practice Recommendations for the Management and Prevention of Cisplatin-Induced Hearing Loss Using Pharmacogenetic Markers. Issue 4 (August 2016)

6. Clinical Practice Recommendations on Genetic Testing of CYP2C9 and VKORC1 Variants in Warfarin Therapy. Issue 4 (August 2015)

7. Clinical Practice Recommendations on Genetic Testing of CYP2C9 and VKORC1 Variants in Warfarin Therapy. Issue 4 (August 2015)

8. Corrigendum to 'SJS/TEN 2019: From science to translation' [J. Dermatol. Sci. 98/1 (2020) 2–12]. Issue 2 (November 2021)

9. Design and Methods of the Pan-Canadian Applying Biomarkers to Minimize Long-Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Nephrotoxicity Study: A Prospective Observational Cohort Study. Issue 1 (16th February 2017)

10. Genetic variants associated with methotrexate-induced mucositis in cancer treatment: A systematic review and meta-analysis. (May 2021)